Previous Article | Next Article ![]()
Infect. Immun., Mar 1997, 951-956, Vol 65, No. 3
PR Beatty, SJ Rasmussen and RS Stephens
Cells infected with Chlamydia trachomatis are lysed by CD8+ T cells in
vitro. The ability of C. trachomatis-elicited spleen cells to lyse target
cells infected with other chlamydial strains was determined by measuring
lysis by immune spleen cells of targets infected with three strains of C.
trachomatis and two strains of C. psittaci. C. trachomatis (lymphogranuloma
venereum [LGV])-elicited immune murine spleen cells lysed target cells
infected with other C. trachomatis serovars, although with lower
sensitivity than they lysed LGV-infected target cells. Additionally, target
cells infected with C. psittaci were lysed by C. trachomatis-elicited
immune spleen cells. Notably, C. psittaci-infected cells were lysed with
greater efficiency than were cells infected with the C. trachomatis strain
used to elicit the immune spleen cells. The lysis of C. psittaci-infected
cells was characterized further and could be only partially accounted for
by CD8+ T-cell- mediated lysis, the remaining lysis being due to an
antigen-nonspecific component. These results indicate that mechanisms of
immunologically mediated lysis differ between C. trachomatis- and C.
psittaci-infected cells. This has important implications for the
interpretation of results obtained with C. psittaci models of infection and
immune resolution, particularly as they may be extrapolated to C.
trachomatis.
Copyright © 1997, American Society for Microbiology
Cross-reactive cytotoxic T-lymphocyte-mediated lysis of Chlamydia trachomatis- and Chlamydia psittaci-infected cells
Francis I. Proctor Foundation and Department of Laboratory Medicine, University of California at San Francisco, 94143, USA.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|